Johnson & Johnson to Pay $230 Million in New York Opioid Epidemic Case Settlement

getty

Johnson & Johnson has agreed to pay $230 million to the state of New York, resolving an opioid lawsuit facing the company.

The settlement includes an additional $33 million in attorney fees and costs for a total of $263 million, according to a statement from J&J. The pharmaceutical giant has also agreed to no longer sell opioids nationwide as part of the deal, which they said they had already stopped doing.

J&J, however, did not admit culpability in their statement. "The settlement is not an admission of liability or wrongdoing by the Company," it read.

The settlement will remove J&J from a trial that is set to begin Tuesday on Long Island involving several other big opioid distributors, though the company has been named in various additional lawsuits in different states for its role in the nationwide opioid epidemic.

Never miss a story - sign up for PEOPLE's free daily newsletter to stay up-to-date on the best of what PEOPLE has to offer, from juicy celebrity news to compelling human interest stories.

RELATED: $5 Million Lawsuit Filed in Wake of Miami Condo Collapse: We Believe 'This Was Preventable'

The Centers for Disease Control and Prevention estimate that nearly 500,000 people have died from overdoses involving opioids between 1999 and 2019. The first wave, the health organization says, began with increased prescribing of opioids in the 1990s.

"The opioid epidemic has wreaked havoc on countless communities across New York state and the rest of the nation, leaving millions still addicted to dangerous and deadly opioids," New York Attorney General Letitia James said in a statement announcing the settlement news Saturday.

"Johnson & Johnson helped fuel this fire, but today they're committing to leaving the opioid business - not only in New York, but across the entire country," she added.

getty

RELATED: Meet the Tennessee Mom Working to End the Opioid Epidemic: 'We Need Empathy and Compassion'

The $230 million will be used to fund opioid prevention, treatment, and education efforts across the state, the statement confirmed.

"While no amount of money will ever compensate for the thousands who lost their lives or became addicted to opioids across our state or provide solace to the countless families torn apart by this crisis, these funds will be used to prevent any future devastation," James said.

"Our trial against the remaining defendants will commence this coming week, where we will lay bare the callous and deadly pattern of misconduct these companies perpetrated as they dealt dangerous and addictive opioids across our state," she continued. "As always, our goal remains getting funds to those devastated by opioids as quickly as possible."